Between 2015 and 2020, over 200 AI/ML-enabled medical devices received regulatory approval in the US and EU, with a strong focus on diagnostics and radiology.
Several of these innovations have already achieved reimbursement status, signaling a shift toward widespread adoption. One notable example covered by Puls Biznesu, one of Poland’s most prominent business publications, is BrainScan AI. This Gdańsk-based startup, led by Szymon Korzekwa, PhD, has developed an AI system to assist radiologists with the analysis of head CT scans. The tool has gained recognition and is currently being piloted in hospital settings.
These developments demonstrate how AI is transforming medical diagnostics—from niche prototypes to reimbursed, clinically meaningful solutions. At Axcellant, we continue to closely monitor these trends and explore how AI-powered tools can enhance imaging quality, trial efficiency, and ultimately, patient care.
Read more in the Puls Biznesu article (in Polish).
A recent publication in npj Digital Medicine explored the use of AI-generated radiology reports — and the results are worth…
The Axcellant team recently traveled to New York to meet with research partners and clinical collaborators from across the U.S.…
What Are Nuclear Medicine Procedures and How Are They Used in Clinical Trials? Nuclear medicine procedures (NMPs) are diagnostic and/or…
Copyright @ 2025 Axcellant